john Wei

Credit: LIGHTFIELD STUDIOS/Adobe Stock The enterprise AI conversation has officially shifted from "What can it tell us?" to "What can it do for us?" We have moved beyond the phase of standalone chatbots into the era of agentic AI—systems capable of planning, using tools, and executing complex workflows with minimal supervision. For CIOs and technology leaders, this transition unsheathes a double-edged sword.

Abstract Binary medical decision-making increasingly demands sequential diagnostic strategies that optimize accuracy while minimizing patient burden and healthcare costs. In prostate cancer diagnosis, many patients undergo unnecessary biopsies despite existing biomarkers and imaging tests that already inform risk stratification. Sequential testing, where tests are selectively administered based on prior results, offers a promising approach to balance diagnostic power with procedural efficiency.